CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
1.990
-0.380 (-16.03%)
At close: Oct 17, 2025, 4:00 PM EDT
2.069
+0.079 (3.98%)
After-hours: Oct 17, 2025, 7:58 PM EDT
CERO Market Cap
CERO has a market cap or net worth of $2.40 million as of October 17, 2025. Its market cap has decreased by -81.52% in one year.
Market Cap
2.40M
Enterprise Value
248.69K
1-Year Change
-81.52%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from $222.99M to $2.40M, a decrease of -98.92%. That is a compound annual growth rate of -68.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.40M | -79.16% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.39B |
| Johnson & Johnson | 461.29B |
| AbbVie | 400.74B |
| UnitedHealth Group | 323.60B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 223.53B |